Elixinol Wellness Statistics
Want to see AU:EXL full AI Analyst Report?
Elixinol Wellness (EXL) Stock Statistics & Valuation Metrics
Total Valuation
Elixinol Wellness has a market cap or net worth of AUD 2.72M. The enterprise value is AUD 5.52M.
- Market Cap
- AUD 2.72M
- Enterprise Value
- AUD 5.52M
Share Statistics
Elixinol Wellness has 454,112,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 454,112,180
- Owned by Insiders
- 1.83%
- Owned by Institutions
- ―
Financial Efficiency
Elixinol Wellness’s return on equity (ROE) is -0.74 and return on invested capital (ROIC) is -35.63%.
- Return on Equity (ROE)
- -0.74
- Return on Assets (ROA)
- -0.34
- Return on Invested Capital (ROIC)
- -35.63%
- Return on Capital Employed (ROCE)
- -0.53
- Revenue Per Employee
- 1.03M
- Profits Per Employee
- -366.67K
- Employee Count
- 15
- Asset Turnover
- 0.97
- Inventory Turnover
- 5.55
Valuation Ratios
The current PE Ratio of Elixinol Wellness is -0.59. Elixinol Wellness’s PEG ratio is 0.00.
- PE Ratio
- -0.59
- PS Ratio
- 0.18
- PB Ratio
- 0.39
- Price to FCF
- -1.04
- Price to Operating Cash Flow
- -0.98
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Elixinol Wellness had revenue of 15.50M and earned -5.50M in profits. Earnings per share was -0.02.
- Revenue
- 15.50M
- Gross Profit
- 752.00K
- Operating Income
- -4.98M
- Pretax Income
- -6.04M
- Net Income
- -5.50M
- EBITDA
- -4.11M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -2.54M and capital expenditures -73,000, giving a free cash flow of -2.62M billion.
- Operating Cash Flow
- -2.54M
- Free Cash Flow
- -2.62M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Elixinol Wellness pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -96.01%
- Earnings Yield
- -140.02%
Stock Price Statistics
- Beta
- -1.16
- 52-Week Price Change
- -11.76%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Elixinol Wellness upcoming earnings date is Feb 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 31, 2026
- Next Earnings Date
- Feb 19, 2027
- Ex-Dividend Date
- ―
Financial Position
Elixinol Wellness as a current ratio of 0.86, with Debt / Equity ratio of 49.99%
- Current Ratio
- 0.86
- Quick Ratio
- 0.46
- Debt to Market Cap
- 1.46
- Net Debt to EBITDA
- -0.56
- Interest Coverage Ratio
- -10.20
Taxes
In the past 12 months, Elixinol Wellness has paid -535.00K in taxes.
- Income Tax
- -535.00K
- Effective Tax Rate
- 0.09
Enterprise Valuation
Elixinol Wellness EV to EBITDA ratio is -2.95, with an EV/FCF ratio of -2.20.
- EV to Sales
- 0.38
- EV to EBITDA
- -2.95
- EV to Free Cash Flow
- -2.20
- EV to Operating Cash Flow
- -2.26
Balance Sheet
Elixinol Wellness has AUD 996.00K in cash and marketable securities with AUD 4.03M in debt, giving a net cash position of -AUD 3.04M billion.
- Cash & Marketable Securities
- AUD 996.00K
- Total Debt
- AUD 4.03M
- Net Cash
- -AUD 3.04M
- Net Cash Per Share
- -AUD 0.01
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is 11.03%, with operating margin of -17.81%, and net profit margin of -23.10%.
- Gross Margin
- 11.03%
- Operating Margin
- -17.81%
- Pretax Margin
- -26.00%
- Net Profit Margin
- -23.10%
- EBITDA Margin
- -12.95%
- EBIT Margin
- -17.81%
Analyst Forecast
The average price target for Elixinol Wellness is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -4.87%
- EPS Growth Forecast
- -9.78%
Scores
- Smart Score
- 5
- AI Score
- 43.2
